Paracetamol/ Pseudoephedrine
Indications
Registered South African indications:
- Allergic rhinitis
- Colds and influenza
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe hypertension
- Coronary artery disease
- Coadministration with monoamine oxidase inhibitors
Cautions
- Pregnancy
- Breastfeeding
- Moderate to severe renal impairment
- Severe hepatic impairment
- Mild to moderate hypertension
- Heart disease
- Diabetes
- Hyperthyroidism
- Elevated intraocular pressure
- Prostatic enlargement
Adult dosage
Forms avail. in SA and covered in this monograph: tab
Symptomatic relief of cold and influenza
Symptomatic relief of nasal and sinus congestion from
-Sinusitis
-Hay fever
Paracetamol/ Pseudoephedrine
500/30 (mg)
- Oral (tab): 2 tab, 4-6hrly; Max: 8 tab/24hrs
500/60 (mg)
- Oral (tab): 1 tab, 8hrly
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: tab, syr
Symptomatic relief of cold and influenza
Symptomatic relief of nasal and sinus congestion from
-Sinusitis
-Hay fever
Paracetamol/ Pseudoephedrine
500/30 (mg)
- Younger than 6 years: Not established for use
- Between 6-12 years: Oral (tab): 1/2-1 tab, 6hrly; Max: 4 tab/24hrs
- Older than 12 years: See adult dosage
500/60 (mg)
- Younger than 6 years: Not established for use
- Between 6-12 years: Oral (tab): 1/2 tab, 8hrly
- Older than 12 years: See adult dosage
160/15 (mg/5ml)
- Younger than 2 years: Not established for use
- Between 2-5 years: Oral (syr): 5ml, 4-6hrly; Max: 4 doses/24hrs
- Between 6-12 years: Oral (syr) 10ml, 4-6hrly; Max: 4 doses/24hrs
- Older than 12 years: Oral (syr) 20ml, 4-6hrly; Max: 4 doses/24hrs
Special populations
Pregnancy
- Caution (Pseudoephedrine)
- Although pseudoephedrine has been in widespread use for many years without apparent ill consequence, there are no specific data on its use during pregnancy. Caution should therefore be exercised by balancing the potential benefit of treatment to the mother against any possible hazards to the developing foetus. Systemic administration of pseudoephedrine, up to 50 times the human daily dosage in rats and up to 35 times the human daily dosage in rabbits, did not produce teratogenic effects
- Epidemiological studies in human pregnancy have shown no ill effects due to paracetamol used in the recommended dosage, but patients should follow the advice of their doctor regarding its use
Breastfeeding
- Caution (Pseudoephedrine)
- Pseudoephedrine is excreted in breast milk in small amounts but the effect of this on breastfed infants is not known. It has been estimated that 0.5 to 0.7% of a single dose of pseudoephedrine ingested by a mother will be excreted in the breast milk over 24 hours
- Paracetamol is excreted in breast milk but not in a clinically significant amount. Available published data do not contraindicate breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
-
Prohibited - In competition
Adverse reactions
Central Nervous System Disorders
- Sleep disturbance
- Hallucinations
Hepatobiliary Disorders
- Chronic hepatic necrosis
Genitourinary Disorders
- Urinary retention
Skin and Subcutaneous Tissue Disorders
- Skin rashes
Immune, Blood and Lymphatic System Disorders
- Thrombocytopenia
- Agranulocytosis
Others
- Papillary necrosis
Interactions
- Tricyclic antidepressants
- Sympathomimetic agents
- Monoamine oxidase inhibitors
- Bretylium
- Betanidine
- Guanethedine
- Debrisoquine
- Methyldopa
- Alpha-adrenergic blocking agents
- Beta-adrenergic blocking agents
- Barbiturates
- Anticonvulsants
- Oral steroid contraceptives
- Metoclopramide
- Domperidone
- Colestyramine
- Warfarin and other coumarins
Monitoring
None routine
Mechanism of action
Paracetamol
Paracetamol increases the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin synthesis. It does not inhibit cyclooxygenase in peripheral tissues and, thus, has no peripheral anti-inflammatory affects.
Pseudoephedrine
Pseudoephedrine acts mainly on alpha- and also on beta adrenergic receptors. It produces vasoconstriction by acting on the alpha adrenergic receptors in the mucosa of the respiratory tract. This results in the decongestant properties of pseudoephedrine.
Dosage forms
- Syrup
- Tablet
Formulation
COMBINATION PREPARATIONS
Paracetamol/ Pseudoephedrine
Tablet 500mg/30mg
- Flusin Sinus (Pharmacare)
- Sinugesic (Pharmacare)
- Sinumax (Janssen)
- Sinutab Sinus Pain Non-Drowsy (Johnson & Jonson) originator
Tablet 500mg/60mg
- Sudafed Sinus Pain (Johnson & Jonson) originator
Syrup (per 5ml) 160mg/15mg
- Sinumax Ped (Janssen) originator
References
1. PI: Sinutab sinus pain nd, J&J:Date of registration: 28 Apr 2009 [https://drive.google.com/drive/folders/12ihNb0_L4zWBgefelgicJvlZCFzC7CeP] 2. PI: Sudafed_tab, J&J: Date of registration: 10 Jun 1992 [https://drive.google.com/drive/folders/12ihNb0_L4zWBgefelgicJvlZCFzC7CeP] 3. PI: Sinumax Paed_syrup, Janssen: Date of registration: 14 Aug 2010 [https://drive.google.com/drive/folders/12ihNb0_L4zWBgefelgicJvlZCFzC7CeP] 4. SmPC: Non-Drowsy Sinutab, McNeil Products Ltd:Last updated on eMC: 05 Dec 2016; Downloaded online 06 Mar 2019 [https://www.medicines.org.uk/emc/medicine/10441] 5. U2D: Acetaminophen and pseudoephedrine: Drug information; Uptodate;Downloaded online 06 Mar 2019 [https://www.uptodate.com/contents/acetaminophen-and-pseudoephedrine-drug-information] 6. NAPOS The Drug Database for Acute Porphyria: N02BE51 Paracetamol, combinations excl. psycholeptics; Accessed online 18 Dec 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=N02BE51] 7. South African Institute for Drug-Free Sport; Sudafed; Accessed online 18 Dec 2018 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
8 products · cached snapshot- Flusin Sinus
- Sinugesic
- Sinumax
- Sinutab Sinus Pain Non-Drowsy
- Sudafed
- Sinumax Ped
TABTablet· 7 products
from R26.62| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Sudafed Sinus Pain | 500 mg;mg | 10 | Johnson & Johnson (Pty) Ltd | R26.62 |
| Sudafed Sinus Pain | 500 mg;mg | 12 | Johnson & Johnson (Pty) Ltd | R31.95 |
| Sinutab Sinus Pain Non-Drowsy | 500 mg;mg | 10 | Johnson & Johnson (Pty) Ltd | R32.38 |
| Sinugesic | 500 mg;mg | 20 | Pharmacare Limited, Woodmead | R45.74 |
| Sinutab Sinus Pain Non-Drowsy | 500 mg;mg | 20 | Johnson & Johnson (Pty) Ltd | R64.77 |
| Flusin Sinus | 500 mg;mg | 24 | Pharmacare Limited, Woodmead | R71.50 |
| Sinumax | 500 mg;mg | 20 | Janssen Pharmaceutica (Pty) Ltd | R85.12 |
SYRSyrup· 1 product
from R49.13| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Sinumax Peddiscontinued | 160 mg/5ml;mg/5ml | 100 | Janssen Pharmaceutica (Pty) Ltd | R49.13 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.